Method to prevent vision loss

An improved method to treat conditions of the eye characterized by ocular neovascularization is provided in which patients are given and initial photodynamic therapy (PDT) treatment to destroy the neovasculature, and then are re-evaluated at least twice during the following 6 months, and retreated a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Strong, H. Andrew, Azab, Mohammad, Reaves, Jr, Troy Albert
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Strong, H. Andrew Azab, Mohammad Reaves, Jr, Troy Albert
description	An improved method to treat conditions of the eye characterized by ocular neovascularization is provided in which patients are given and initial photodynamic therapy (PDT) treatment to destroy the neovasculature, and then are re-evaluated at least twice during the following 6 months, and retreated as necessary. Preferably, three retreatments are provided.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07060695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07060695</sourcerecordid><originalsourceid>FETCH-uspatents_grants_070606953</originalsourceid><addsrcrecordid>eNrjZJD1TS3JyE9RKMlXKChKLUvNK1EoyyzOzM9TyMkvLuZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSVAxcXx6UWJIMrA3MDMwMzS1JgIJQCyyyUV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Method to prevent vision loss</title><source>USPTO Issued Patents</source><creator>Strong, H. Andrew ; Azab, Mohammad ; Reaves, Jr, Troy Albert</creator><creatorcontrib>Strong, H. Andrew ; Azab, Mohammad ; Reaves, Jr, Troy Albert ; Novartis AG ; QLT, Inc</creatorcontrib><description>An improved method to treat conditions of the eye characterized by ocular neovascularization is provided in which patients are given and initial photodynamic therapy (PDT) treatment to destroy the neovasculature, and then are re-evaluated at least twice during the following 6 months, and retreated as necessary. Preferably, three retreatments are provided.</description><language>eng</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7060695$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64038</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7060695$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Strong, H. Andrew</creatorcontrib><creatorcontrib>Azab, Mohammad</creatorcontrib><creatorcontrib>Reaves, Jr, Troy Albert</creatorcontrib><creatorcontrib>Novartis AG</creatorcontrib><creatorcontrib>QLT, Inc</creatorcontrib><title>Method to prevent vision loss</title><description>An improved method to treat conditions of the eye characterized by ocular neovascularization is provided in which patients are given and initial photodynamic therapy (PDT) treatment to destroy the neovasculature, and then are re-evaluated at least twice during the following 6 months, and retreated as necessary. Preferably, three retreatments are provided.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZJD1TS3JyE9RKMlXKChKLUvNK1EoyyzOzM9TyMkvLuZhYE1LzClO5YXS3AwKbq4hzh66pcUFiSVAxcXx6UWJIMrA3MDMwMzS1JgIJQCyyyUV</recordid><startdate>20060613</startdate><enddate>20060613</enddate><creator>Strong, H. Andrew</creator><creator>Azab, Mohammad</creator><creator>Reaves, Jr, Troy Albert</creator><scope>EFH</scope></search><sort><creationdate>20060613</creationdate><title>Method to prevent vision loss</title><author>Strong, H. Andrew ; Azab, Mohammad ; Reaves, Jr, Troy Albert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_070606953</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Strong, H. Andrew</creatorcontrib><creatorcontrib>Azab, Mohammad</creatorcontrib><creatorcontrib>Reaves, Jr, Troy Albert</creatorcontrib><creatorcontrib>Novartis AG</creatorcontrib><creatorcontrib>QLT, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Strong, H. Andrew</au><au>Azab, Mohammad</au><au>Reaves, Jr, Troy Albert</au><aucorp>Novartis AG</aucorp><aucorp>QLT, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Method to prevent vision loss</title><date>2006-06-13</date><risdate>2006</risdate><abstract>An improved method to treat conditions of the eye characterized by ocular neovascularization is provided in which patients are given and initial photodynamic therapy (PDT) treatment to destroy the neovasculature, and then are re-evaluated at least twice during the following 6 months, and retreated as necessary. Preferably, three retreatments are provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_grants_07060695
source	USPTO Issued Patents
title	Method to prevent vision loss
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T21%3A05%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Strong,%20H.%20Andrew&rft.aucorp=Novartis%20AG&rft.date=2006-06-13&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07060695%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true